How Genital Herpes Affects You: Treatment and Prevention

1. The Impact of Genital Herpes on Fertility and Overall Health 

Genital herpes not only causes physical symptoms but also has significant effects on the fertility and psychosocial health of the patient.

Impact on Male Fertility

Genital herpes may affect male fertility by reducing sperm count. A 2013 study indicated that herpes is associated with low sperm count in tested males. Although herpes does not cause complete infertility, its potential effect on male sperm count is an important point that needs to be communicated to males in the target audience. This provides specific information about a potential impact on reproductive health, helping them make informed decisions about their reproductive health.

1.1. Impact on Female Fertility

Current research shows that genital herpes does not pose a real risk to female fertility. Symptoms such as sores or blisters around the genitals do not directly affect the internal reproductive organs. However, having herpes can make safe sexual intercourse more difficult, especially during outbreaks. During these periods, avoiding sexual intercourse is recommended to reduce the risk of transmission to a partner.

1.2. Genital Herpes in Pregnancy and Risk to Newborns

Herpes infection during pregnancy is a critical health issue that requires special attention. Pregnant women can transmit the Herpes simplex virus (HSV) to the fetus during pregnancy or to the newborn during childbirth, especially during a vaginal delivery. The risk of transmission to the newborn is significantly higher (25-50%) if the mother contracts the infection for the first time in the late stages of pregnancy (third trimester), as the fetus has not yet developed sufficient antibodies to fight the virus. Conversely, if the mother was infected with herpes before pregnancy, the risk of transmission to the baby is very low (less than 1%). Neonatal herpes is a rare but extremely serious condition that can lead to dangerous complications such as brain damage, meningitis, pneumonia, seizures, blindness, deafness, or even death for the newborn. Neonatal herpes is a rare but extremely serious complication that can cause disability or death for newborns. This highlights the paramount importance of herpes screening in pregnant women and close management during pregnancy, especially in the third trimester. To prevent neonatal herpes, pregnant women with a history of genital herpes should receive suppressive antiviral therapy with Acyclovir from the 36th week of pregnancy until delivery to reduce the risk of active viral recurrence. If prodromal symptoms or active herpes lesions are present at the time of labor, an elective Cesarean section should be performed to minimize the risk of transmission to the infant.

1.3. Psychosocial Impact

In addition to physical symptoms, genital herpes also causes a significant psychosocial burden for patients. Sufferers may face social stigma, feelings of anxiety, stress, and negative impacts on sexual relationships. Stress has been proven to be a common trigger for herpes outbreaks. The psychosocial impact of herpes, including stigma and stress, is an often-overlooked but very important aspect. Therefore, herpes management is not just medical treatment but also psychological support and education to reduce stigma, encourage open communication, and help patients live positively with their condition. Providing information on support resources and encouraging open communication can help patients better cope with their condition, which is especially important for target groups who may face more social pressure.

2. Treatment of Genital Herpes

Currently, there is no definitive cure for genital herpes. The virus will remain permanently in the body, hiding in the nerve ganglia for life. However, existing treatment methods are very effective in controlling symptoms and reducing the risk of transmission.

2.1. Treatment Principles and Goals

The main goals of genital herpes treatment are:

• Control symptoms, reduce pain and discomfort caused by outbreaks.
• Shorten the duration of outbreaks.
• Reduce the frequency and severity of recurrent episodes.
• Limit HSV viral shedding (the phenomenon where the virus reactivates and replicates, then escapes from the mucosal and skin cells, which may or may not cause symptoms). These shedding episodes can pose a risk of transmission to others, so limiting viral shedding reduces the risk of transmission to a partner.

Antiviral treatment does not completely cure the disease but only controls symptoms and reduces transmission. Antiviral drugs do not eliminate the latent virus or affect the risk or severity of recurrence after discontinuing treatment. This is very important to avoid patient misunderstanding about treatment expectations and the importance of long-term therapy adherence, especially suppressive therapy.

2.2. Common Antiviral Medications

The three main antiviral drugs approved by the U.S. Food and Drug Administration (FDA) and widely used to treat genital herpes are Acyclovir, Valacyclovir, and Famciclovir. These drugs work by inhibiting the multiplication of the virus in infected cells, but they do not kill the virus.

2.3. Treatment Duration and Recurrence Management

Genital herpes management includes treating acute outbreaks and prophylactic therapy to reduce the frequency of recurrence.

• Treatment of the First Episode: All patients with a first outbreak should be treated with antivirals due to the potential for prolonged illness and severe symptoms. Treatment usually lasts 7-10 days.
• Treatment of Recurrence (Episodic Therapy): This therapy is most effective if started within 1 day of lesion onset or during the prodromal phase (pre-warning sensation). The treatment duration is shorter, usually 1-5 days depending on the regimen.
• Preventative Treatment (Suppressive Therapy): This therapy is for individuals who have frequent recurrences (e.g., ≥ 6 episodes/year) or who wish to reduce the frequency of recurrence and the risk of transmission. Suppressive therapy can reduce recurrence frequency by 70-80% and viral shedding by over 90%. This therapy can be continued indefinitely but requires annual re-evaluation. Notably, prophylactic therapy is recommended for pregnant women from the 36th week of pregnancy to reduce the risk of transmission to the newborn.
• For Immunocompromised Patients (e.g., HIV infection): Outbreaks in these individuals can be prolonged, severe, and atypical. Dosage and treatment duration may need to be extended. It should be noted that suppressive antiviral therapy in HIV-infected individuals may reduce the clinical manifestations of HSV but does not reduce the risk of HIV or HSV-2 transmission to a partner.

Although suppressive therapy does not completely prevent transmission, the significant reduction in outbreak frequency and viral shedding is a huge benefit to the patient’s quality of life and an important prevention tool. For sex workers and MSM, this can help them maintain safer sexual activity and reduce the psychological burden associated with fear of transmission.

Table 1: Common Antiviral Treatment Regimens for Genital Herpes

2.4. Can Genital Herpes be Cured Completely?

As presented, genital herpes is a chronic viral infection, and currently, there is no definitive cure. The virus will remain latent in the nerve ganglia for life. However, existing treatment methods are very effective in controlling symptoms, reducing the frequency of recurrence, and reducing the risk of transmission.

3. Prevention of Genital Herpes and Advice for Living with the Condition

Preventing genital herpes requires a combination of strategies, and living with the disease requires a comprehensive approach that includes both medical and psychological aspects.

3.1. Effective Prevention Measures

• Abstinence from Sexual Intercourse: The only way to completely avoid STIs is to not engage in vaginal, anal, or oral sexual intercourse.
• Long-Term Monogamy: Maintaining a long-term monogamous relationship with a partner who is not infected with herpes is an effective prevention measure.
• Correct and Consistent Condom Use: Male latex condoms can significantly reduce the risk of HSV-2 transmission from male to female, but they do not eliminate the risk completely. This is because the virus can be transmitted through skin areas not covered by the condom. Clarifying that condoms reduce rather than completely eliminate the risk of transmission is crucial to avoid creating a false sense of security. This leads to the need for a combination of prevention strategies.
• Avoid Sexual Intercourse During Symptoms: Do not engage in sexual intercourse (vaginal, anal, oral) when you or your partner have herpes symptoms (e.g., sores, blisters, tingling sensation).
• Partner Takes Daily Antiviral Medication: If your partner has herpes, their daily use of antiviral medication (suppressive therapy) can significantly reduce the risk of transmission to you. This provides a more comprehensive and realistic prevention strategy, especially important for target groups with high sexual activity frequency.
• Intimate Area Hygiene: Washing the intimate area before and after sexual intercourse does not prevent herpes transmission.
• Pre-Exposure Prophylaxis (PrEP): Some studies show that PrEP with TDF/FTC (HIV prophylactic drug) can reduce the risk of HSV-2 infection in HIV-negative individuals but is not effective in preventing HSV-2 infection in HIV-infected individuals.

3.2. The Importance of Counseling and Support

Counseling is an indispensable part of genital herpes management. Patients need to be counseled about the natural history of the disease, the risk of sexual and perinatal transmission, and risk reduction methods. Disclosing one’s status to current and future partners is crucial for making safe and responsible decisions together. Psychological counseling and support are extremely important for people living with herpes, especially the target groups. The psychological burden, stigma, and anxiety about transmission can severely affect the quality of life. Providing information on support resources and encouraging open communication can help patients better cope with their condition. This shows that providing only medical information is insufficient; patients need support to cope with stigma, anxiety, and relationship issues.

3.3. Safe Living and Minimizing Transmission Risk

With the right medication, an open and honest approach, and good knowledge about the virus, people living with genital herpes can still maintain a healthy sexual life and live like anyone else.

• Adherence to Treatment: Adhering to prophylactic antiviral treatment can significantly reduce the frequency of outbreaks and the risk of transmission.
• Stress Management: Implementing stress-reduction measures in life is very important, as stress can be a trigger for outbreaks.
• Regular Health Check-ups: Regular health check-ups and comprehensive STI screening are necessary to timely detect and manage other health conditions.

4. Conclusion

Regarding fertility, genital herpes may reduce sperm count in males but has little effect on female fertility. However, the risk of mother-to-child transmission during pregnancy, especially if the initial infection occurs late in pregnancy, is a serious issue that can cause neonatal herpes with dangerous complications. Close management of pregnancy and the indication for Cesarean section when necessary are paramount to protect the newborn. Finally, living with genital herpes is not just medical management but also psychological and social support. Reducing stigma, encouraging open communication with partners, and seeking support resources are key factors that help patients maintain a good quality of life. Although there is no vaccine or complete cure yet, ongoing research into new therapies and vaccines offers hope for future advances.

Recommendations:

1. Raise Awareness: Enhance public education campaigns, especially targeting high-risk groups (sex workers, MSM), about the transmission routes of genital herpes, including transmission through oral sex and asymptomatic viral shedding.
2. Encourage Early Screening: Promote regular testing for high-risk groups, including type-specific serological testing when asymptomatic, and counsel on the importance of early diagnosis.
3. Integrate Health Services: Ensure that HIV and other STI testing is performed concurrently with genital herpes diagnosis to provide comprehensive healthcare services.
4. Comprehensive Counseling: Provide in-depth counseling to patients on treatment options (including suppressive therapy), strategies to minimize the risk of transmission to partners, and how to cope with the psychosocial impact of the disease.
5. Psychosocial Support: Develop and promote psychological support resources and support groups for people living with genital herpes to help them cope with stigma and stress.
6. Strict Pregnancy Management: Ensure pregnant women are screened for genital herpes and receive appropriate prophylactic therapy from the 36th week of pregnancy, as well as the indication for Cesarean section when active lesions are present at the time of labor.

This article is written by Dr Đỗ Hữu Đạt. The doctor has many years of in-depth experience in reproductive and sexual health care.